Today & tomorrow: Our enduring commitment in hematology
September 07, 2023
Today & tomorrow: Our enduring commitment in hematology  >
Cancer Cells
May 01, 2023
Putting patients first: Transforming clinical lessons into development strategies >
Blood cells
April 27, 2023
Addressing the burden of anemia in MDS >
Light the Night event
December 09, 2021
Team BMS 'Lights The Night' and sets fundraising record >
December 08, 2021
The potential of our pipeline >
Cell Therapy Manufacturing Facilities
November 09, 2021
Company celebrates cell therapy manufacturing facility progress in U.S. and Europe >
BMS supports Light the Night event
July 19, 2021
Why support of Light The Night is 'at the heart of Bristol Myers Squibb' >
Evolving Needs of People with Beta Thalassemia
June 03, 2021
Evolving needs of people with beta thalassemia >
Bristol Myers Squibb researchers conducting a lab tour in 2019
March 22, 2021
Multiple myeloma action month: innovation and research >
Patients have a single goal: The best care possible. But too often African American patients with multiple myeloma aren’t getting it
January 13, 2021
Patients have a single goal: The best care possible. But too often African American patients with multiple myeloma aren't getting it >
Team BMS surpasses fundraising goal for Light The Night
December 18, 2020
Team BMS surpasses fundraising goal for Light The Night >
In Cellular Therapy, Patients and Physicians are Always Learning
December 01, 2020
In Cellular Therapy, Patients and Physicians Are Always Learning >